Neonatal Diseases and Abnormalities
7
2
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
29%
2 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Prospective Registry for Long-term Outcomes Following FETO in Severe Left and Right CDH
Evaluation of Bili-ruler, a Low-cost, Plastic Icterometer for Community-based Screening of Jaundice in Newborns
Azithromycin and Ampicillin for Late PPROM
Melatonin for Pulmonary Hypertension in Full Term Neonates
OPTI-Prem: Optimising Neonatal Service Provision for Preterm Babies Born Between 27 and 31 Weeks of Gestation in England
Nasal High Frequency in Preterm Neonates
Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization